Skip to main content

Hypertension and Coronary Microvascular Disease

  • Chapter
Hypertension and the Heart

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 432))

Abstract

Arterial hypertension represents the most frequent kind of left ventricular pressure overload in man. As former studies in our clinic have shown, three distinct types of left ventricular hypertrophy may occur: concentric — irregular — eccentric (1). The main functional features of these different types of hypertrophy imply: (I) Left ventricular systolic ejection fraction is normal, despite of significant or excessive increase in left ventricular muscle mass as long as ventricular volume is not increased. Diastolic function is impaired at all stages of LV hypertrophy. (II) There is an inverse relationship between systolic wall stress, i.e. left ventricular afterload, and left ventricular function. (Ill) Systolic wall stress is directly correlated with LV myocardial oxygen consumption. (IV) In hypertensive hypertrophy there is, even at normal coronary arteriogram, significant reduction in coronary reserve (2) (Fig. 1). Both, reduction in coronary reserve and diastolic dysfunction already may occur in the prehypertrophic state of hypertensive heart disease.

With support of SFB 242 “Koronare Herzkrankheit — Prävention und Therapie akuter Komplikationen.”

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Strauer BE: Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 1979; 44: 999–1006

    Article  PubMed  CAS  Google Scholar 

  2. Strauer BE: Coronary hemodynamics in hypertensive heart disease. Am J Med 1988; 84: 45–54

    Article  PubMed  CAS  Google Scholar 

  3. Anversa P, Ricci R, Olivetti G: Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy. A review. J Am Coll Cardiol 1986; 7: 1140–1149

    Article  PubMed  CAS  Google Scholar 

  4. Katz A: cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 1990; 322: 100–110

    Article  PubMed  CAS  Google Scholar 

  5. Nadal-Ginard B, Mahdavi V: Molecular mechanisms of cardiac gene expression, pp 65–80. In: Strauer BE (ed): The heart in Hypertension. Springer-Verlag, New York 1993

    Google Scholar 

  6. Capasso JM, Palackal T, Olivetti G, Anversa P: Left ventricular failure — induced by long-term hypertension in rats. Circ Res 1990; 66: 1400–1412

    Article  PubMed  CAS  Google Scholar 

  7. Weber KT, Sun Y, Guarda E: Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994; 23: 869–877

    Article  PubMed  CAS  Google Scholar 

  8. Schwartzkopff B, Motz W, Knauer S, Frenzel H, Strauer BE: Morphometric investigations of intramyocardial arterioles in right septal endomyocardial biopsy of patients with arterial hypertension and left ventricular hypertrophy. J cardiovasc Pharmacol, Suppl 1 1992; 20: 12–17

    Google Scholar 

  9. Tillmanns H, Steinhausen M, Leinberger H, Thederau H, Kubier W: Pressure measurement in the terminal vascular bed of the epicardium of rats and cats. Cir Res 1981; 49: 1202–1211

    Article  CAS  Google Scholar 

  10. Mulvany MJ: Vascular growth in hypertension. J Cardiovasc Pharmacol 1992; 22: 7–11

    Google Scholar 

  11. Opherk D, Mall G, Zebe H et al: Reduction of coronary reserve. A mechanism for angina pectoris in patients with arterial hypertension and normal arteries. Circulation 1984; 69: 1–7

    Article  PubMed  CAS  Google Scholar 

  12. Schwartzkopff B, Motz W, Frenzel H et al.: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993–1003

    Article  PubMed  CAS  Google Scholar 

  13. Hudlicka O, Brown M, Egginton S: Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992; 72: 369–417

    PubMed  CAS  Google Scholar 

  14. Moritz AR, Oldt MR: Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 1937; 13:679–728

    PubMed  CAS  Google Scholar 

  15. Dzau VJ, Gibbons GH, Cooke JP, Omoigui N: Vascular biology and medicine in the 1990s. Scope, concepts, potentials and perspectives. Circulation 1993; 87: 705–719

    Article  PubMed  CAS  Google Scholar 

  16. Scott-Burden T, Resink TJ, Baur U, Bürgin M, Bühler FR: Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension 1989; 13: 295–304

    Article  PubMed  CAS  Google Scholar 

  17. James JN: Morphologic characteristics and functional significance of focal fibromuscular dysplasia of small coronary arteries. Am J Cardiol 1990; 65: 12G-22G

    Article  Google Scholar 

  18. Schwartzkopff B, Frenzel H, Dieckerhoff J et al.: Morphometric investigation of humen myocardium in arterial hypertension and valvular aortic stenosis. Eur Heart J, Suppl D 1992; 13: 17–20

    Article  PubMed  Google Scholar 

  19. Schwartzkopff B, Motz W, Strauer BE: Repair of human myocardial structure by chronic treatment with ACE-inhibitors in hypertensive heart disease. Circulation Suppl. I 1994; 90: 343

    Google Scholar 

  20. Diez J, Laviades C, Mayor G, Gil MJ, Monreal I: Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation 1995; 91: 1450–1456

    Article  PubMed  CAS  Google Scholar 

  21. Motz W, Vogt M, Scheler S et al.: Prophylaxe mit gefäßaktiven Substanzen. Z Kardiol, Suppl. 4 1992; 81: 199–204

    PubMed  Google Scholar 

  22. Motz W, Strauer BE: Improvement of coronary flow reserve after long-term therapy with Enalapril. Hypertension 1996; 27: 1031–1058

    Article  PubMed  CAS  Google Scholar 

  23. Vogt M, Motz W, Strauer BE: Antihypertensive Langzeittherapie mit Isradipin. Arzneimittel Forschung; 44: 1321–1318

    Google Scholar 

  24. Motz W, Vogt M, Scheler S, Schwartzkopff B, Strauer BE: Verbesserung der Koronarreserve nach Hypertrophieregression durch antihypertensive Therapie mit einem Beta-Rezeptorenblocker. Dtsch Med Wochenschr 1993; 118: 540–553

    Article  Google Scholar 

  25. Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83: 1771–1779

    Article  PubMed  CAS  Google Scholar 

  26. Schiffrin EL, Deng LY, Larochelle P: Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23: 83–91

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Strauer, B.E., Schwartzkopff, B. (1997). Hypertension and Coronary Microvascular Disease. In: Zanchetti, A., Devereux, R.B., Hansson, L., Gorini, S. (eds) Hypertension and the Heart. Advances in Experimental Medicine and Biology, vol 432. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5385-4_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5385-4_23

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7458-9

  • Online ISBN: 978-1-4615-5385-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics